Qingdao Vland Biotech, Inc. (603739.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 12.26

From 52W high−28.74%

Volume3.44M

Market capCNY 3.05B

P/E (TTM)43.7x

P/S (TTM)2.2x

Div yield0.82%

Key dataSep 18, 2026

Open

CNY 12.26

From 52W high

−28.74%

Volume

3.44M

Market cap

CNY 3.05B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.9x

P/E (TTM)

43.7x

RSI (14)

45.5

MomentumView details →

1D Return

−1.95%

YTD Return

−13.50%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

43.7x

EV/EBITDA

14.9x

EV/Sales

2.6x

P/S (TTM)

2.2x

P/B (TTM)

1.7x

ProfitabilityView details →

Gross Margin

44.75%

Net Margin

5.57%

EBITDA Margin

17.55%

ROE (TTM)

4.34%

ROA (TTM)

2.54%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

+4.23%

EPS YoY

+28.76%

FCF YoY

−19.03%

Revenue CAGR 3Y

+5.51%

EPS CAGR 3Y

+0.00%

EBITDA YoY

—

MomentumView details →

1D Return

−1.95%

YTD Return

−13.50%

1Y Return

−11.94%

RSI (14)

45.5

vs 50D SMA

+0.43%

vs 200D SMA

−11.85%

Capital & dividendView details →

Debt/Equity

0.37x

Current Ratio

1.19x

Quick Ratio

0.97x

Div Yield

0.82%

Div Rate

CNY 0.10

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.40B

Net Income (TTM)

78.10M

Op. CF (TTM)

124.59M

Latest newsMore news →

Vland Biotech announced that Qingying Granules, a jointly developed national class IV new veterinary drug, obtained a new veterinary drug registration certificate with a 3-year monitoring period.5d ago

Weilan Biological released its 2026 first-half results, reporting revenue of 710 million yuan, up 8.80% year-on-year, and net profit attributable to shareholders of 38.56 million yuan, up 44.33%.24d ago

Similar companies

uniQure N.V.QURE Jiangsu Recbio Technology Co., Ltd.02179.HK MBX Biosciences, Inc. Common StockMBX 凯因科技688687.SH Viva Biotech Holdings01873.HK Celldex Therapeutics, Inc.CLDX Find similar companies →

Latest newsMore news →

Vland Biotech announced that Qingying Granules, a jointly developed national class IV new veterinary drug, obtained a new veterinary drug registration certificate with a 3-year monitoring period.5d ago Weilan Biological released its 2026 first-half results, reporting revenue of 710 million yuan, up 8.80% year-on-year, and net profit attributable to shareholders of 38.56 million yuan, up 44.33%.24d ago